全球栓塞預防裝置市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計抗栓塞裝置（EPD）的市場規模將從 2025 年的 7,571.4 億美元成長到 2034 年的 15,935.5 億美元，2026 年至 2034 年的複合年成長率為 8.62%。

抗栓塞裝置（EPD）市場正在成長，這主要得益於頸動脈支架置入術和經導管主動脈瓣置換術術（TAVR）等介入心臟病學數量的增加。這些裝置有助於防止血管介入過程中碎片進入血液，從而降低中風風險並改善患者預後。人口老化和心血管疾病盛行率上升是推動市場擴張的主要因素。

關鍵成長要素包括微創心血管手術的進步、設備設計的改進以及支持EPD應用的臨床證據不斷增加。介入性心臟病專家的認知度提高和監管部門的核准也促進了市場滲透率的提升。專注於提高過濾效率和簡化操作的技術創新正在提高EPD的採用率。

隨著全球心血管手術數量的持續成長，前景依然樂觀。與新一代導管系統的整合以及向周邊血管介入領域的拓展，可望拓寬其應用範圍。然而，在某些地區，健保報銷政策和高成本可能會構成挑戰。持續的技術創新和臨床檢驗對於永續發展仍然至關重要。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球栓塞預防器材市場：依產品分類

• 市場分析、洞察與預測
• 遠端閉塞裝置
• 近端閉塞裝置
• 遠端濾器

第5章 全球栓塞預防裝置市場：依應用領域分類

• 市場分析、洞察與預測
• 心血管疾病
• 神經血管疾病
• 周邊血管疾病

第6章 全球栓塞預防設備市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院和診所
• 門診手術中心
• 其他

第7章 全球栓塞預防器材市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • InspireMDInc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Medtronic Plc
  • Cardinal Health
  • Contego Medical, LLC
  • Silk Road MedicalInc
  • Edwards Lifesciences Corporation
  • Lepu Medical Technology

The Embolic Protection Devices Market size is expected to reach USD 1593.55 Billion in 2034 from USD 757.14 Billion (2025) growing at a CAGR of 8.62% during 2026-2034.

The embolic protection devices (EPD) market has grown due to increasing cardiovascular interventions, particularly in procedures such as carotid artery stenting and transcatheter aortic valve replacement (TAVR). These devices help prevent debris from entering the bloodstream during vascular interventions, reducing stroke risk and improving patient outcomes. Aging populations and rising prevalence of cardiovascular diseases have significantly contributed to market expansion.

Key growth drivers include advancements in minimally invasive cardiac procedures, improved device designs, and growing clinical evidence supporting EPD use. Increased awareness among interventional cardiologists and supportive regulatory approvals have also strengthened market penetration. Technological innovations focusing on better filtration efficiency and ease of deployment have enhanced adoption rates.

Future prospects are favorable as cardiovascular procedure volumes continue to rise globally. Integration with next-generation catheter systems and expansion into peripheral vascular interventions may broaden application scope. However, reimbursement policies and high device costs may present challenges in some regions. Continued innovation and clinical validation will remain central to sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Distal Occlusion Devices
• Proximal Occlusion Devices
• Distal Filters

By Application

• Cardiovascular Diseases
• Neurovascular Diseases
• Peripheral Vascular Diseases
• By-End-User
• Hospitals & Clinics
• Ambulatory Surgery Centers
• Others

COMPANIES PROFILED

• InspireMD, Inc, Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Cardinal Health, Contego Medical, LLC, Silk Road Medical, Inc, Edwards Lifesciences Corporation, Lepu Medical Technology

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EMBOLIC PROTECTION DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Distal Occlusion Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Proximal Occlusion Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Distal Filters Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EMBOLIC PROTECTION DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Neurovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Peripheral Vascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EMBOLIC PROTECTION DEVICES MARKET: BY BY-END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast By-end-user
• 6.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EMBOLIC PROTECTION DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By By-end-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By By-end-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By By-end-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By By-end-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By By-end-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL EMBOLIC PROTECTION DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 InspireMDInc
  • 9.2.2 Boston Scientific Corporation
  • 9.2.3 Abbott Laboratories
  • 9.2.4 Medtronic Plc
  • 9.2.5 Cardinal Health
  • 9.2.6 Contego Medical, LLC
  • 9.2.7 Silk Road MedicalInc
  • 9.2.8 Edwards Lifesciences Corporation
  • 9.2.9 Lepu Medical Technology